Article
A Second Letter to Dr Peter Marks, US Food and Drug Administration
5 min read A drug safety physician’s alert to Dr. Peter Marks (U.S. Food and Drug Administration) regarding the need for clear guidance or regulation concerning
5 min read A drug safety physician’s alert to Dr. Peter Marks (U.S. Food and Drug Administration) regarding the need for clear guidance or regulation concerning
4 min read A drug safety physician’s message to Dr. Marks (U.S. FDA) regarding risk evaluation of anaphylaxis with the Pfizer-BioNTech Covid-19 Vaccine.